milrinone has been researched along with digoxin in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (16.67) | 18.7374 |
| 1990's | 3 (16.67) | 18.2507 |
| 2000's | 7 (38.89) | 29.6817 |
| 2010's | 5 (27.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Schwarz, RP; Stander, H; Tandon, PK | 1 |
| DiBianco, R; Kostuk, W; Moran, J; Schlant, RC; Shabetai, R; Wright, R | 1 |
| Doyle, JT; Fein, SA; Ferrick, AM; Ferrick, KJ | 1 |
| Riley, CM | 1 |
| Joseph, G; Klaus, W; Zhao, Y | 1 |
| Abe, Y; Ishisu, R; Nakano, T; Onishi, K; Sekioka, K; Ueda, Y | 1 |
| Hii, JT; Horowitz, JD; Jarrett, RG; Ritchie, RH; Wuttke, RD; Zeitz, CJ | 1 |
| Bolling, SF; Geltz, A; Spoor, MT | 1 |
| Adams, S; Mather, PJ; Rubin, S; Saltzman, HE; Sharma, K; Whellan, DJ | 1 |
| Donlan, SM; Gheorghiade, M; Pang, PS; Quattromani, E | 1 |
| Coons, JC; McGraw, M; Murali, S | 1 |
| Chapo, J; Ida, KK; Joly, KM; Liles, JT; Plato, CF | 1 |
| Bai, YL; Chen, YY; Chu, QJ; Li, J; Li, WJ; Zhang, Q | 1 |
4 review(s) available for milrinone and digoxin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Renal dysfunction in heart failure patients: what is the evidence?
Topics: Acute Disease; Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Cardiac Catheterization; Cardiac Pacing, Artificial; Clinical Trials as Topic; Digoxin; Heart Failure; Humans; Milrinone; Mineralocorticoid Receptor Antagonists; Natriuretic Peptide, Brain; Renal Insufficiency, Chronic; Treatment Outcome; Ultrafiltration | 2007 |
Therapy for acute heart failure syndromes.
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiotonic Agents; Digoxin; Diuretics; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Milrinone; Mineralocorticoid Receptor Antagonists; Morphine; Nitroprusside; Practice Guidelines as Topic; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Severity of Illness Index; Survival Analysis; Syndrome; Treatment Outcome | 2009 |
Pharmacotherapy for acute heart failure syndromes.
Topics: Angiotensin-Converting Enzyme Inhibitors; Digoxin; Diuretics; Dobutamine; Heart Failure; Humans; Milrinone; Morphine; Natriuretic Peptide, Brain; Nitroglycerin; Nitroprusside; Practice Guidelines as Topic; Vasodilator Agents | 2011 |
3 trial(s) available for milrinone and digoxin
| Article | Year |
|---|---|
Application of new two-sample tests to data from a randomized placebo-controlled heart-failure trial.
Topics: Adult; Data Interpretation, Statistical; Digoxin; Double-Blind Method; Female; Heart Failure; Humans; Male; Middle Aged; Milrinone; Pyridones; Randomized Controlled Trials as Topic; Statistics as Topic; Vasodilator Agents | 1990 |
A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure.
Topics: Administration, Oral; Cardiotonic Agents; Chronic Disease; Clinical Trials as Topic; Digoxin; Double-Blind Method; Drug Therapy, Combination; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Milrinone; Pyridones; Random Allocation; Stroke Volume; Vasodilator Agents | 1989 |
The positive inotropic effects of milrinone but not of digoxin are attenuated at short cycle lengths.
Topics: Cardiotonic Agents; Digoxin; Electrocardiography; Female; Hemodynamics; Humans; Male; Middle Aged; Milrinone; Myocardial Contraction; Phosphodiesterase Inhibitors; Time Factors | 2000 |
11 other study(ies) available for milrinone and digoxin
| Article | Year |
|---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Effect of milrinone on steady-state digoxin levels in congestive heart failure.
Topics: Cardiotonic Agents; Digoxin; Heart Failure; Humans; Male; Middle Aged; Milrinone; Pyridones | 1989 |
Stability of milrinone and digoxin, furosemide, procainamide hydrochloride, propranolol hydrochloride, quinidine gluconate, or verapamil hydrochloride in 5% dextrose injection.
Topics: Digoxin; Drug Combinations; Drug Stability; Drug Storage; Furosemide; Glucose; Indicators and Reagents; Milrinone; Procainamide; Propranolol; Pyridones; Quinidine; Solutions; Temperature; Verapamil | 1988 |
[Pharmacologic action profile of crataegus extract in comparison to epinephrine, amirinone, milrinone and digoxin in the isolated perfused guinea pig heart].
Topics: Amrinone; Animals; Cardiotonic Agents; Coronary Circulation; Crataegus; Digoxin; Epinephrine; Guinea Pigs; Heart; Heart Rate; In Vitro Techniques; Male; Milrinone; Myocardial Contraction; Plant Extracts; Plants, Medicinal; Pyridones; Refractory Period, Electrophysiological; Vasoconstrictor Agents | 1995 |
Changes in calcium transient and left ventricular function during positive inotropic stimulation and myocardial ischemia in indo-1-loaded beating guinea pig heart.
Topics: Animals; Calcium; Cardiotonic Agents; Digoxin; Fluorescent Dyes; Guinea Pigs; Indoles; Male; Milrinone; Myocardial Contraction; Myocardial Ischemia; Pyridones; Spectrometry, Fluorescence; Ventricular Function, Left | 1996 |
Flexible versus nonflexible mitral valve rings for congestive heart failure: differential durability of repair.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Cardiomyopathy, Dilated; Combined Modality Therapy; Databases, Factual; Digoxin; Diuretics; Drug Therapy, Combination; Equipment Design; Female; Follow-Up Studies; Heart Failure; Heart Ventricles; Heart-Assist Devices; Humans; Male; Middle Aged; Milrinone; Mitral Valve; Mitral Valve Insufficiency; Norepinephrine; Pliability; Postoperative Complications; Prospective Studies; Recurrence; Reoperation; Spironolactone; Stroke Volume; Time Factors; Tricuspid Valve Insufficiency; Ultrasonography | 2006 |
Age exacerbates chronic catecholamine-induced impairments in contractile reserve in the rat.
Topics: Aging; Animals; Cardiotonic Agents; Catecholamines; Digoxin; Drug Administration Schedule; Isoproterenol; Milrinone; Myocardial Contraction; Rats | 2011 |
A comparison of the effects of digoxin, ouabain and milrinone on naloxone-precipitated withdrawal syndrome in mice.
Topics: Animals; Cardiotonic Agents; Digoxin; Female; Male; Mice; Milrinone; Morphine; Motor Activity; Naloxone; Ouabain; Sodium-Potassium-Exchanging ATPase; Substance Withdrawal Syndrome; Weight Loss | 2012 |